Core Laboratories Inc. /DE/ 8-K

What Happened
On March 23, 2026, Core Laboratories Inc. (CLB) issued a press release announcing revisions to its previously issued earnings guidance for the first quarter of 2026. The full press release text is attached to the Form 8-K as Exhibit 99.1. The filing was furnished under Regulation FD and signed by CFO Christopher S. Hill.

Key Details

• Date of disclosure: March 23, 2026 (Regulation FD disclosure, Item 7.01).
• Subject: Revised earnings guidance for Q1 2026 (details provided in attached press release, Exhibit 99.1).
• Filing status: Information and exhibit are furnished (not “filed”) under the Exchange Act.
• Form 8-K signed by: Christopher S. Hill, Chief Financial Officer.

Why It Matters
Revised quarterly earnings guidance is material because it updates management’s expectations for near-term financial performance and can influence investor estimates, analyst models, and the share price. Retail investors should read the attached press release for the specific revised guidance figures and monitor subsequent filings (earnings releases, 10-Q) for confirmation and additional detail.